May 21, 2026 06:00PM
May 21, 2026 06:00PM
May 7, 2026 05:57PM
May 7, 2026 04:01PM
Apr 20, 2026 08:30AM
Apr 6, 2026 05:55AM
Apr 3, 2026 01:30PM Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
Mar 25, 2026 11:50AM
Mar 25, 2026 11:50AM
Feb 26, 2026 05:21PM
Feb 26, 2026 04:01PM
Dec 30, 2025 08:00AM
Dec 30, 2025 08:00AM
Dec 4, 2025 07:10AM Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement
Dec 4, 2025 07:02AM
Dec 4, 2025 07:00AM
Nov 6, 2025 06:48PM
Nov 6, 2025 04:01PM
Nov 6, 2025 04:00PM
Nov 6, 2025 04:00PM
Oct 13, 2025 04:01PM FDA extends review timeline for Denali's Hunter syndrome treatment
Oct 13, 2025 04:01PM
Aug 11, 2025 04:03PM
Aug 11, 2025 04:01PM
Jul 7, 2025 08:03AM
Jul 7, 2025 08:00AM
May 6, 2025 05:38PM
May 6, 2025 04:01PM Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome
Apr 2, 2025 08:04AM
Apr 2, 2025 08:00AM
Feb 27, 2025 05:02PM
Feb 27, 2025 04:01PM
Nov 6, 2024 04:01PM
Aug 1, 2024 08:51AM
Aug 1, 2024 06:45AM Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
May 7, 2024 06:35PM
May 7, 2024 04:01PM
Feb 27, 2024 09:30AM
Feb 27, 2024 08:05AM
Jan 8, 2024 08:00AM
Nov 7, 2023 05:23PM
Nov 7, 2023 04:01PM Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
Aug 8, 2023 05:18PM
Aug 8, 2023 04:01PM
May 8, 2023 04:49PM
May 8, 2023 04:01PM
Feb 27, 2023 04:39PM
Feb 27, 2023 04:01PM
Feb 27, 2023 04:01PM Denali Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
Jan 9, 2023 08:00AM

1,198,729 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All